Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07480967 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Show 4 more changesShow less
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site contact updated
    • Publications: details revised at 8 of 9 entries
  2. Secondary endpoints: details revised at 3 of 3 entries
    • Publications revised (9)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled trial evaluates the comparative effectiveness of platelet-rich plasma (PRP) therapy and prolotherapy in patients with plantar fasciitis. Both interventions are commonly used regenerative injection therapies intended to improve pain and functional outcomes in patients who do not respond adequately to conventional conservative treatments. Participants diagnosed with plantar fasciitis will be randomly assigned to receive either PRP injection or prolotherapy. The results of this study aim to identify the more effective injection therapy for improving clinical outcomes in patients with plantar fasciitis
Trial Details
NCT Number NCT07480967
Lead Sponsor Bangladesh Medical University
Conditions
(from sponsor)		 Planter Fasciitis
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov